DE69010523D1 - Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen. - Google Patents

Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.

Info

Publication number
DE69010523D1
DE69010523D1 DE69010523T DE69010523T DE69010523D1 DE 69010523 D1 DE69010523 D1 DE 69010523D1 DE 69010523 T DE69010523 T DE 69010523T DE 69010523 T DE69010523 T DE 69010523T DE 69010523 D1 DE69010523 D1 DE 69010523D1
Authority
DE
Germany
Prior art keywords
infections
kit
preventing
composition
treating hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69010523T
Other languages
English (en)
Inventor
Franklin Volvovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MICROGENESYS Inc
Original Assignee
MICROGENESYS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MICROGENESYS Inc filed Critical MICROGENESYS Inc
Application granted granted Critical
Publication of DE69010523D1 publication Critical patent/DE69010523D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69010523T 1989-03-03 1990-03-01 Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen. Expired - Lifetime DE69010523D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31827289A 1989-03-03 1989-03-03

Publications (1)

Publication Number Publication Date
DE69010523D1 true DE69010523D1 (de) 1994-08-18

Family

ID=23237447

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69010523T Expired - Lifetime DE69010523D1 (de) 1989-03-03 1990-03-01 Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.

Country Status (8)

Country Link
EP (1) EP0385909B1 (de)
JP (1) JPH03163027A (de)
AT (1) ATE108335T1 (de)
AU (1) AU635001B2 (de)
CA (1) CA2011299A1 (de)
DE (1) DE69010523D1 (de)
DK (1) DK0385909T3 (de)
IL (1) IL93599A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
CA2065010A1 (en) * 1989-08-23 1991-02-24 Brian Seed Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
AU651228B2 (en) * 1991-05-31 1994-07-14 Genentech Inc. Treatment of HIV-associated immune thrombocytopenic purpura
AU680916B2 (en) * 1993-05-07 1997-08-14 Biomerieux, Inc. HIV immunogenic complexes
EP0893507A1 (de) * 1997-07-25 1999-01-27 Institut Gustave Roussy Verwendung von MHC Klass II Liganden (CD4 und LAG-3) als Adjuvanz für Impfungen und von LAG-3 in der Behandlung von Krebs
WO2018207023A2 (en) * 2017-05-10 2018-11-15 Albajuna Therapeutics, S.L. Fc-fusion protein derivatives with high dual hiv antiviral and immunomodulatory activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US344304A (en) * 1886-06-22 Spindle-support
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
IE872748L (en) * 1986-10-16 1988-04-16 Arjomari Europ Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
EP0272858A3 (de) * 1986-12-15 1989-07-12 Repligen Corporation Rekombinante HIV-Hüllen-Proteine, hergestellt in Insektenzellen
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff
WO1988007376A1 (en) * 1987-03-27 1988-10-06 Hiroshi Okajima Remedy for viral diseases
JPS6463394A (en) * 1987-09-04 1989-03-09 Kyowa Hakko Kogyo Kk Novel chimera polypeptide

Also Published As

Publication number Publication date
IL93599A0 (en) 1990-12-23
AU635001B2 (en) 1993-03-11
DK0385909T3 (da) 1994-08-15
JPH03163027A (ja) 1991-07-15
CA2011299A1 (en) 1990-09-03
EP0385909A3 (de) 1991-04-10
EP0385909B1 (de) 1994-07-13
AU5061090A (en) 1990-11-01
EP0385909A2 (de) 1990-09-05
ATE108335T1 (de) 1994-07-15

Similar Documents

Publication Publication Date Title
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE77554T1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
NO893256D0 (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE3874606D1 (de) Behandlung von viraler infektion.
HUT71422A (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
DE69231465D1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
HU901594D0 (en) Process for the preparation of new chemical compounds
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ATE56878T1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von virus-infektionen.
DE3676806D1 (de) Pharmazeutische zusammensetzung und behandlung.
DE69431731D1 (de) Orale oder intramuskuläre Behandlung von Pankreaskrebs durch wasserunlösliches S-Camptothecin mit geschlossenem Lactonring
ATE85750T1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.

Legal Events

Date Code Title Description
8332 No legal effect for de